80 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
ITGR vs. EW: Which Stock Should Value Investors Buy Now? https://www.zacks.com/stock/news/2256237/itgr-vs-ew-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2256237 Apr 16, 2024 - ITGR vs. EW: Which Stock Is the Better Value Option?
Three Reasons to Retain Integer Holdings (ITGR) Stock for Now https://www.zacks.com/stock/news/2272958/three-reasons-to-retain-integer-holdings-itgr-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2272958 May 13, 2024 - Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
ITGR vs. EW: Which Stock Is the Better Value Option? https://www.zacks.com/stock/news/2192337/itgr-vs-ew-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2192337 Dec 01, 2023 - ITGR vs. EW: Which Stock Is the Better Value Option?
Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now https://www.zacks.com/stock/news/2192765/reasons-to-retain-stryker-syk-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2192765 Dec 04, 2023 - Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
Community Health (CYH) Sells Three Florida Facilities for $294M https://www.zacks.com/stock/news/2193200/community-health-cyh-sells-three-florida-facilities-for-294m?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193200 Dec 04, 2023 - Community Health (CYH) divests three hospitals in Florida to Tampa General Hospital, substantiating its endeavor to intensify its focus on high-growth business areas.
Here's Why You Should Invest in Haemonetics (HAE) Right Now https://www.zacks.com/stock/news/2193129/here-s-why-you-should-invest-in-haemonetics-hae-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2193129 Dec 04, 2023 - Investors are optimistic about Haemonetics (HAE) on consistent growth performance and raised guidance.
West Pharmaceutical's (WST) New Launch to Expand Portfolio https://www.zacks.com/stock/news/2193729/west-pharmaceutical-s-wst-new-launch-to-expand-portfolio?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193729 Dec 05, 2023 - West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.
Here's Why You Should Retain OPKO Health (OPK) Stock for Now https://www.zacks.com/stock/news/2194846/here-s-why-you-should-retain-opko-health-opk-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2194846 Dec 07, 2023 - OPKO Health's (OPK) potential in Rayaldee raises optimism about the stock.
AMN Healthcare's (AMN) New Tie-Up to Boost Patient Outcome https://www.zacks.com/stock/news/2195558/amn-healthcare-s-amn-new-tie-up-to-boost-patient-outcome?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2195558 Dec 08, 2023 - AMN Healthcare's (AMN) collaboration is likely to bolster its portfolio of products and simplify the language procurement process for customers.
Masimo's (MASI) ORi Favored by Study for PaO2 Information https://www.zacks.com/stock/news/2196904/masimo-s-masi-ori-favored-by-study-for-pao2-information?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196904 Dec 12, 2023 - Masimo's (MASI) latest study indicates that ORi can be a valuable tool to provide information on arterial oxygenation even during OLV.

Pages: 12345678

<<<Page 4>